bioRxiv Science⌕ Search

Biology subjects

Angel, A.

Publications and source records attributed to Angel, A..

9 recordsLinked to original sources

The shape of evolution: persistent homology of genetic-distancedata as an observable of reticulate processes in pathogen andplant genomes

Evolutionary biology has long theorized processes--recombination, lineage divergence, drug-resistance sweeps, introgression, refugial persistence--whose signatures in genomic data are incompatible with tree structure. We argue that the shape of genetic-distance data, formalized through simplicial complexes and quantified through persistent homology, is a direct observable of these processes. The Vietoris--Rips filtration of a genetic-distance matrix yields the Betti numbers {beta}0 (connected components), {beta}1 (loops), and {beta}2 (cavities); we read {beta}1 not as a literal count of recombination events but as a quantity that is monotone in effective recombination above a sampling-dependent geometric baseline, and we organise the resulting shapes into a four-letter alphabet of topological primitives (K1 clonal, K2 divergence, K3 reticulation, K4 higher-order reticulation). Coalescent and Wright--Fisher simulations establish the two load-bearing claims: {beta}1 rises monotonically with the recombination rate over six orders of magnitude, and persistent-homology features separate reticulate from non-reticulate histories with 98--100% recall (the residual confusion falls entirely within the non-reticulate K1/K2 pair, which {beta}1 does not distinguish). We then apply the pipeline to four empirical systems. (i) On the MalariaGEN Pf7 Plasmodium falciparum dataset (n = 20,864, 33 countries), per-population {beta}1 spans two orders of magnitude and diverges significantly from a label--shuffle null (median 20.5, range 8-32); the ordering runs opposite to recombination rate-freely-recombining African populations sit lowest and clonal/swept Southeast Asian and Papuan populations highest--because at the population scale {beta}1 is dominated by demographic structure rather than recombination rate, a point we reconcile explicitly with the controlled dose-response. (ii) Colombian Cauca SP-resistant samples carry {beta}1 = 12 against a near-clonal SP-sensitive baseline of {beta}1 = 5 (and two orders of magnitude more total persistence), the high-{beta}1, multi-origin band of K3 consistent with resistance carried on several genomic backgrounds. (iii) The Cambodia artemisinin sweep (2008-2018) traces a K3 [->] K1 trajectory, {beta}1 rising to a mid-sweep peak of 45 and collapsing to 13 at fixation--to our knowledge the first direct observation of a selective-sweep transient in topological coordinates, with the caveat that the per-bin values are medians of three subsamples with wide bars. (iv) On Arabidopsis thaliana 1001 Genomes data, Iberian relict populations (Spain, {beta}1/n = 0.64) exceed post-glacial-expansion populations (Sweden 0.54; United Kingdom 0), generalising the framework beyond pathogens. A P. falciparum mitochondrial negative control recovers {beta}1 = 0 across all subsamples, establishing pipeline specificity. Moving above the 1-skeleton, {beta}2 is zero at the clonal/expansion limits and positive across the reticulate systems; a controlled two-vs-three-way admixture simulation confirms that {beta}2 separates regimes that share a {beta}1 profile, while the further suggestion that the ratio = {beta}2/{beta}1 separates microevolutionary from macroevolutionary timescales is presented, given the small number of systems and the absence of a {beta}2 null, as a hypothesis for future testing. Together these results demonstrate that the topology of genetic-distance data is an evolutionary observable, with immediate implications for drug-resistance surveillance in P. falciparum. Author summaryBiologists usually picture the history of life as a tree, in which lineages split and never rejoin. Many of the most consequential evolutionary events break that picture: malaria parasites recombine in the mosquito gut, drug-resistant strains arise repeatedly on different genetic backgrounds, and plant populations that survived the Ice Age in southern refuges carry tangled ancestry that no tree can represent. We ask a different question of genetic data--not "what tree fits?" but "what shape does the data make?" --and answer it with topological data analysis, which measures shape through three counts (the Betti numbers) of clusters, loops, and higher-order cavities. Loops appear when lineages recombine and rejoin. We show, in simulations and in real Plasmodium falciparum and Arabidopsis thaliana genomes, that the loop count rises with recombination above a baseline set by finite sampling, cleanly separates recombining from clonal histories, and tracks a real artemisinin-resistance sweep in Cambodia as it rises and collapses over a decade. A non-recombining mitochondrial control correctly shows no loops. The shape of genetic data is thus a direct, tree-free readout of evolutionary process, with immediate value for drug-resistance surveillance.

evolutionary biology↗

Predicting Immunotherapy Response Through Chemotherapy-Induced Tumor Microenvironment Remodeling

BackgroundChemotherapy before immunotherapy improves outcomes in multiple cancers, but the benefit is heterogeneous: only some tumors undergo the immune remodeling that makes subsequent immunotherapy effective, and no biomarker identifies these patients prospectively, leading to uniform use of chemo-immunotherapy and avoidable toxicity. MethodsA random forest model of tumor-microenvironment (TME) favorability, trained on 1,936 immunotherapy-treated patients, was applied to 334 paired pre-/post-chemotherapy biopsies across 19 studies to identify TME "converters," from which a 50-gene baseline signature was derived. The signature was tested in IMvigor210 (the only cohort containing both treatment arms) and in five independent chemo-immunotherapy validation cohorts, and for specificity against 22 immunotherapy-only cohorts. ResultsOf 209 paired-biopsy patients with unfavorable baseline TME, 61 (29%) converted to a favorable state after chemotherapy; converters were indistinguishable from non-converters at baseline by cell composition, motivating a gene-level signature. In IMvigor210, the signature discriminated responders among chemotherapy-primed patients with unfavorable baseline TME (AUC = 0.80, 95% CI: 0.67-0.94) but showed no signal in the trials immunotherapy-only arm (interaction OR = 4.42, p = 0.006). Across five independent chemo-immunotherapy cohorts, responders consistently scored higher than non-responders, yielding a significant pooled effect by meta-analysis (pooled g = 0.59, 95% CI: 0.11-1.08, p = 0.017) and individual significance in two (LUD2015-005, p = 0.009; GSE165252, p = 0.02). A meta-analysis of 22 immunotherapy-only cohorts constrained any effect there to a small magnitude (Hedges g = 0.08, 95% CI: -0.08 to 0.23), and five established immune signatures did not reproduce this treatment-context specificity. Converter tumors harbored coordinated baseline programs of proliferative stress, innate and adaptive immune readiness, and functional vasculature. ConclusionsA baseline transcriptomic signature predicts immunotherapy response specifically in chemotherapy-primed patients, a treatment-context specificity not shown by established immune biomarkers. These findings support prospective validation of the signature to guide chemotherapy- immunotherapy sequencing. SignificanceChemotherapy is now added to immunotherapy across a growing list of cancers, yet every eligible patient receives it even though only some tumors need it, and current biomarkers (PD-L1, tumor mutational burden, microsatellite instability) cannot identify which. We report the first biomarker to predict benefit from the chemotherapy component itself: a baseline gene-expression signature that flags likely responders in chemotherapy-primed settings while remaining silent under immunotherapy alone. This treatment-context specificity shifts the biomarker question from "who responds to immunotherapy" to "who needs the chemotherapy," pointing toward a way to spare patients unnecessary toxicity and rationally sequence chemo-immunotherapy.

Cancer Biology↗

xCell 2.0: Robust Algorithm for cell type Proportion Estimation Predicts Response to Immune Checkpoint Blockade

BackgroundAccurate estimation of cell type proportions from bulk gene expression data is essential for understanding the cellular heterogeneity underlying complex tissues and diseases. Here, we introduce xCell 2.0, an advanced version of the xCell algorithm, featuring a training function that permits the utilization of any reference dataset. xCell 2.0 generates cell type gene signatures using an improved methodology, including automated handling of cell type dependencies and more robust signature generation. MethodsWe benchmarked xCell 2.0 against ten popular deconvolution methods using nine human and mouse reference sets and 26 validation datasets, encompassing 1,749 samples and 67 cell types. Additionally, we validated xCell 2.0 using the independent Deconvolution DREAM Challenge dataset. As an applicative test case, we curated pan-cancer data of 2,007 patients pre-treated with immune checkpoint blockade (ICB). Features of the tumor microenvironment (TME) were generated using xCell 2.0 and other methods and fed into a LightGBM model using nested cross-validation to obtain robust predictions of ICB response. ResultsBenchmarking results showed that xCell 2.0 outperformed all other tested methods across distinct reference datasets, demonstrating superior accuracy and consistency across diverse biological contexts. xCell 2.0 also showed the best performance in minimizing spillover effects between related cell types. In the ICB response prediction task, xCell 2.0-derived TME features significantly improved prediction accuracy compared to models using only cancer type and treatment information, and outperformed other deconvolution methods and established ICB prediction scores. ConclusionsxCell 2.0 is a versatile and robust tool for cell type deconvolution that maintains high performance across various reference types and biological contexts. It is available both via a web application and as a Bioconductor-compatible package, equipped with a large collection of pre-trained cell type signatures for human and mouse research. The improved prediction of ICB responses highlights the potential of xCell 2.0 to advance precision medicine in cancer and other diseases.

bioinformatics↗

Global and Gene-specific Transcriptional Responses to Acute Stress

Nucleosomes may regulate transcription by controlling access to promoters by transcription factors and RNA polymerase II (Pol2). Potentially active genes display nucleosome depleted regions flanked by positioned -1 and +1 nucleosomes. On yeast genes, the transcription start site (TSS) is on the upstream face of the +1 nucleosome, but whether precise +1 nucleosome positioning controls Pol2 access to the TSS remains unclear. Here, using acute nutrient starvation to rapidly reprogramme the genome, we show highly dynamic upstream or downstream shifts in the position of +1 nucleosomes, coincident with levels of transcriptionally engaged Pol2 at 58% of genes. Transcript level changes broadly reflect Pol2 occupancy changes with a delay but can be further influenced by Pub1 or Puf3 dependent changes in transcript degradation rates. The response to acute stress has a second component as we also observed genome-wide changes in Pol2 distribution on genes, independent of changes in Pol2 occupancy, with Pol2 accumulating upstream of a +170 nt stalling site. Mathematical modelling supports a global increase in promoter-proximal early transcription termination as a major component of the global stress response. Thus, we uncover a two-component transcriptional response to stress, one focused on the +1 nucleosome, the second on Pol2 itself. O_LIA two-component responses to acute stress involving a gene-specific response and a global response C_LIO_LIDynamic shifting of +1 nucleosome position with transcriptional activation or repression. C_LIO_LIGlobal targeting of Pol2 leading to early transcription termination on acute stress C_LI

molecular biology↗

Mapping Human Transient Transcriptomes Using Single Nucleotide Resolution 4sU Sequencing (SNU-Seq)

Genomes are pervasively transcribed, leading to stable and unstable transcripts that influence 3-dimensional genome organisation and gene regulation. High sensitivity and nucleotide resolution are required to resolve mammalian nascent transcriptomes. Here, we exploit the sensitivity of 4-thio-uridine (4sU) metabolic pulse-labelling to develop two nucleotide-resolution methods: Single-Nucleotide resolution 4sU sequencing (SNU-Seq) and size-fractionated 4sU-Seq (sf4sU-Seq). sf4sU-Seq involves gel isolation of abundant 4sU-labelled promoter proximal nascent transcripts, enabling nucleotide resolution mapping of transcription start sites and promoter proximal pauses (PPPs) on the same transcript. SNU-Seq exploits 3 end RNA-Seq, using bacterial poly(A) polymerase (bPAP) to polyadenylate the 3 ends of nascent transcripts and create oligo(dT)-primed libraries. The artificial poly(A) tail marks the precise position of polymerase on a transcription unit. SNU-Seq read levels are similar at pre-mRNAs and enhancers genome-wide and read spikes in pre-mRNA outputs map pauses, PPPs and polyadenylation sites. SNU-Seq enables discovery of thousands of unannotated regions of divergent transcription and helps define hundreds of the more than 10,000 regions of primed non-transcribed acetylated open chromatin that induce divergent nascent transcripts within 0.5h of IFN-{gamma} treatment in Hep3B cells. Thus, combining chromatin analysis with SNU-Seq reveals the transcriptional responsiveness of an epigenetically primed human genome. HIGHLIGHTSO_LISNU-Seq maps nascent transcripts with bp resolution, high sensitivity and low cost C_LIO_LIsf4sU-Seq resolves TSS and PPP at the same gene, complementing SNU-Seq C_LIO_LI1000s of divergently transcribed enhancers resolved by SNU-Seq C_LIO_LIRapid IFN{gamma} dependent transcriptional induction from primed Hep3B epigenome C_LI GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=165 SRC="FIGDIR/small/452379v2_ufig1.gif" ALT="Figure 1"> View larger version (47K): org.highwire.dtl.DTLVardef@da6239org.highwire.dtl.DTLVardef@16692c6org.highwire.dtl.DTLVardef@12e30f7org.highwire.dtl.DTLVardef@190c98f_HPS_FORMAT_FIGEXP M_FIG C_FIG

molecular biology↗

Spt4 Facilitates the Movement of RNA Polymerase II through the +2 Nucleosomal Barrier

Spt4 is a transcription elongation factor, with homologues in organisms with nucleosomes. Structural and in vitro studies implicate Spt4 in transcription through nucleosomes, yet the in vivo function of Spt4 is unclear. Here we assessed the precise position of Spt4 during transcription and the consequences of loss of Spt4 on RNA polymerase II (RNAPII) dynamics and nucleosome positioning in Saccharomyces cerevisiae. In the absence of Spt4, the spacing between gene-body nucleosomes increases and RNAPII accumulates upstream of the nucleosomal dyad, most dramatically at nucleosome +2. Spt4 associates with elongating RNAPII early in transcription and its association dynamically changes depending on nucleosome positions. Together, our data show that Spt4 regulates early elongation dynamics, participates in co-transcriptional nucleosome positioning, and promotes RNAPII movement through the gene-body nucleosomes, especially the +2 nucleosome.

genomics↗

FACT is recruited to the +1 nucleosome of transcribed genes and spreads in a Chd1-dependent manner

The histone chaperone FACT occupies transcribed regions where it plays prominent roles in maintaining chromatin integrity and preserving epigenetic information. How it is targeted to transcribed regions, however, remains unclear. Proposed models for how FACT finds its way to transcriptionally active chromatin include docking on the RNA polymerase II (RNAPII) C-terminal domain (CTD), recruitment by elongation factors, recognition of modified histone tails and binding partially disassembled nucleosomes. Here, we systematically tested these and other scenarios in Saccharomyces cerevisiae and found that FACT binds transcribed chromatin, not RNAPII. Through a combination of experimental and mathematical modeling evidence, we propose that FACT recognizes the +1 nucleosome, as it is partially unwrapped by the engaging RNAPII, and spreads to downstream nucleosomes aided by the chromatin remodeler Chd1. Our work clarifies how FACT interacts with genes, suggests a processive mechanism for FACT function, and provides a framework to further dissect the molecular mechanisms of transcription-coupled histone chaperoning. HighlightsO_LIHigh-resolution mapping of FACT localization in yeast C_LIO_LIFACT binds partially unwrapped nucleosomes in transcribed genes, not RNAPII C_LIO_LIFACT distribution along genes requires Chd1 C_LIO_LIProcessive mechanism for FACT function C_LI

molecular biology↗

H3K4me3 is neither instructive for, nor informed by, transcription.

H3K4me3 is a near-universal histone modification found predominantly at the 5 region of genes, with a well-documented association with gene activity. H3K4me3 has been ascribed roles as both an instructor of gene expression and also a downstream consequence of expression, yet neither has been convincingly proven on a genome-wide scale. Here we test these relationships using a combination of bioinformatics, modelling and experimental data from budding yeast in which the levels of H3K4me3 have been massively ablated. We find that loss of H3K4me3 has no effect on the levels of nascent transcription or transcript in the population. Moreover, we observe no change in the rates of transcription initiation, elongation, mRNA export or turnover, or in protein levels, or cell-to-cell variation of mRNA. Loss of H3K4me3 also has no effect on the large changes in gene expression patterns that follow galactose induction. Conversely, loss of RNA polymerase from the nucleus has no effect on the pattern of H3K4me3 deposition and little effect on its levels, despite much larger changes to other chromatin features. Furthermore, large genome-wide changes in transcription, both in response to environmental stress and during metabolic cycling, are not accompanied by corresponding changes in H3K4me3. Thus, despite the correlation between H3K4me3 and gene activity, neither appear to be necessary to maintain levels of the other, nor to influence their changes in response to environmental stimuli. When we compare gene classes with very different levels of H3K4me3 but highly similar transcription levels we find that H3K4me3-marked genes are those whose expression is unresponsive to environmental changes, and that their histones are less acetylated and dynamically turned-over. Constitutive genes are generally well-expressed, which may alone explain the correlation between H3K4me3 and gene expression, while the biological role of H3K4me3 may have more to do with this distinction in gene class.

genomics↗

Antisense transcription-dependent chromatin signature modulates sense transcription and transcript dynamics

Antisense transcription is widespread in genomes. Despite large differences in gene size and architecture, we find that yeast and human genes share a unique, antisense transcription-associated chromatin signature. We asked whether this signature is related to a biological function for antisense transcription. Using quantitative RNA-FISH, we observed changes in sense transcript distributions in nuclei and cytoplasm as antisense transcript levels were altered. To determine the mechanistic differences underlying these distributions, we developed a mathematical framework describing transcription from initiation to transcript degradation. At GAL1, high levels of antisense transcription alters sense transcription dynamics, reducing rates of transcript production and processing, while increasing transcript stability, which is also a genome-wide association. Establishing the antisense transcription-associated chromatin signature through disruption of the Set3C histone deacetylase activity is sufficient to similarly change these rates even in the absence of antisense transcription. Thus, antisense transcription alters sense transcription dynamics in a chromatin-dependent manner.\n\n\n\nO_FIG O_LINKSMALLFIG WIDTH=198 HEIGHT=200 SRC=\"FIGDIR/small/187237_fig8.gif\" ALT=\"Figure 8\">\nView larger version (52K):\norg.highwire.dtl.DTLVardef@4f872corg.highwire.dtl.DTLVardef@1339662org.highwire.dtl.DTLVardef@1d62cc2org.highwire.dtl.DTLVardef@148f24_HPS_FORMAT_FIGEXP M_FIG Graphical Abstract\n\nC_FIG In this work, Brown et al. provide a mechanistic understanding of the effect of antisense transcription on the production and fate of sense transcripts. Antisense transcription buffers genes against the action of the Set3 lysine deacetylase, thus altering rates of transcript production, processing and stability. O_LIConserved antisense transcription-dependent chromatin architecture near promoters\nC_LIO_LIAntisense transcription alters sense transcription dynamics and transcript stability\nC_LIO_LIAntisense transcription functions in a chromatin-dependent manner\nC_LIO_LIIncreased acetylation by set3{Delta} mimics high antisense transcriptional dynamics\nC_LI

systems biology↗